About one in every eight Americans is currently taking a GLP-1, according to a recent poll from KFF, formerly known as the Kaiser Family Foundation
Cosmos Study May 28, 2026 Dual-Team Study Team A:Kersten Bartelt, RNBenjamin GuilliatJoe Deckert, PhD Team B:Louis Kazaglis, MDJacob GasserJoel Simon Key Findings Three months after stopping a GLP-1, 40% of patients had further improved their HbA1c compared to when they discontinued the GLP-1, 48% kept some of their improvement, and just 12% had a worse HbA1c compared to their pre-GLP-1 level
Lastly, GLP-1 signals to your brain (specifically the hypothalamus) that youre full
Neuron 2017;95:757-78.ArticlePubMedPMC 51
Their conversation will explore the realities of navigating treatment over timeincluding experiences with stigma, barriers to access, and gaps in care